First Light Asset Management, LLC Macrogenics Inc Transaction History

First Light Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$18.89 - $32.46 $1.39 Million - $2.39 Million	-73,558 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $1.26 Million - $1.59 Million	-78,112 Reduced 51.5%	73,558 $1.4 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $1.4 Million - $1.71 Million	90,132 Added 146.47%	151,670 $2.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	61,538	61,538 $1.08 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $195M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.